subject area of
- 4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency Academic Article
- A head-to-tail tandem organization of hsp70 genes in Trypanosoma-cruzi Academic Article
- Acute Trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia: reversal by nifurtimox treatment Academic Article
- Binding mode and potency of N-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting Trypanosoma cruzi CYP51 Academic Article
- Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives Academic Article
- Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway Academic Article
- In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi Academic Article
- Machine learning models and pathway genome data base for trypanosoma cruzi drug discovery Academic Article
- Myocarditis, microbes and autoimmunity Academic Article
- Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain Academic Article
- Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents Academic Article
- Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors Academic Article
- Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase Academic Article
- Synthesis of macrocyclic trypanosomal cysteine protease inhibitors Academic Article
- The influence of T cell subsets on Trypanosoma cruzi multiplication in different organs Academic Article